- Home
- YETI vs NRIX Comparison
YETI vs NRIX Comparison
Compare YETI & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YETI | NRIX |
|---|---|---|
| Founded | 2006 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | YETI | NRIX |
|---|---|---|
| Price | $42.81 | $25.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 14 |
| Target Price | ★ $54.31 | $34.50 |
| AVG Volume (30 Days) | 1.3M | ★ 1.9M |
| Earning Date | 11-12-2026 | 10-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.06 | ★ 3.26 |
| Revenue | ★ $1,868,494,000.00 | $76,987,000.00 |
| Revenue This Year | $7.63 | $786.93 |
| Revenue Next Year | $7.07 | N/A |
| P/E Ratio | $41.60 | ★ $7.82 |
| Revenue Growth | 2.11 | ★ 99.31 |
| 52 Week Low | $32.26 | $11.19 |
| 52 Week High | $53.99 | $28.23 |
Technical Indicators
Market Signals| Indicator | YETI | NRIX |
|---|---|---|
| Relative Strength Index (RSI) | 54.70 | 58.20 |
| Support Level | $38.46 | $24.61 |
| Resistance Level | $44.10 | $28.23 |
| Average True Range (ATR) | 1.24 | 1.21 |
| MACD | 0.43 | 0.39 |
| Stochastic Oscillator | 74.68 | 81.41 |
Price Performance
Historical ComparisonAbout YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.